Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypersensitivity pneumonitis: a multifaceted deceiving disorder.

Moisés Selman1

  • 1Instituto Nacional de Enfermedades Respiratorias, Tlalpan 4502, CP 14080, México DF, México. moiselman@salud.gob.mx

Clinics in Chest Medicine
|August 28, 2004
PubMed
Summary

Hypersensitivity pneumonitis (HP) is an immune lung condition caused by environmental exposures. Diagnosis requires multiple tests, and current treatments include avoiding triggers and prednisone, with a need for new therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Idiopathic pulmonary fibrosis risk loci in East Asian populations mirror those of European populations.

American journal of respiratory and critical care medicine·2026
Same author

Imbalanced immune cell network and suboptimal cell activation: signatures associated with disease severity in vaccine-naïve COVID-19 patients.

Frontiers in immunology·2026
Same author

Age, sex, smoking-specific prevalence and progression in interstitial lung abnormality: patient-level meta-analysis.

Annals of the American Thoracic Society·2026
Same author

Utility of Z Scores for Defining Progressive Pulmonary Fibrosis in Interstitial Lung Disease.

Archivos de bronconeumologia·2026
Same author

Artificial intelligence in idiopathic pulmonary fibrosis: advances, challenges and future directions.

The European respiratory journal·2025
Same author

Preserving conceptual clarity: why hypersensitivity pneumonitis should remain a separate entity from bronchiolocentric interstitial pneumonia.

The European respiratory journal·2025

Area of Science:

  • Immunology
  • Pulmonology
  • Environmental Medicine

Background:

  • Hypersensitivity pneumonitis (HP) encompasses immune-mediated lung diseases.
  • Caused by repeated exposure to environmental agents.
  • HP presents diversely, mimicking other lung conditions.

Purpose of the Study:

  • To summarize the diagnostic challenges and therapeutic strategies for hypersensitivity pneumonitis.
  • To highlight the need for novel pharmacological interventions.

Main Methods:

  • Diagnosis relies on integrating clinical, environmental, radiological, physiological, and pathological data.
  • Absence of a single diagnostic gold standard.

Main Results:

  • HP diagnosis is challenging due to its varied presentation.

Related Experiment Videos

  • Chronic HP poses diagnostic difficulties even for experienced pathologists.

    • Conclusions:

    • Current management involves exposure avoidance and prednisone therapy.
    • There is an urgent need for new anti-inflammatory, immunoregulatory, and antifibrotic drugs for HP and other interstitial lung diseases.